跳至主要内容
临床试验/NCT04336228
NCT04336228进行中(未招募)4 期

The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2020年4月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
46
试验地点
1
主要终点
Habit formation outcome 1: response times for each day of training

研究概览

简要总结

The aim of this project is to investigate:

  • The status of the central serotonin (5-hydroxytryptamine, 5-HT) system in compulsive behaviour and how it is affected by sub-chronic escitalopram administration
  • The mechanisms underlying how sub-chronic administration of escitalopram affects the central 5-HT system
  • How changes in cognitive performance, including the balance between habitual and goal-directed mechanisms, are affected in compulsive behaviour by boosting 5-HT function
  • How functional brain changes in cognitive function measured with magnetic resonance imaging relate to altered 5-HT function following escitalopram administration.

详细描述

Previous studies have shown that 5-HT is strongly implicated in compulsive behaviours in experimental animals. Manipulation of 5-HT influences neuronal interactions underlying action selection. Reduced forebrain 5-HT causes perseveration and impairs goal-directed behaviour under reward but not punishment. Dysfunctional 5-HT neurotransmission has also been implicated in Obsessive-Compulsive Disorder (OCD) based on the selective efficacy of relatively high doses of selective serotonin reuptake inhibitors (SSRIs) in treating this disorder. Hitherto, it is unknown whether there is a primary defect in the serotonergic system or whether SSRIs ameliorate symptoms by modulating other brain neurotransmitter pathways. So far, only one study of central 5-HT release in OCD patients has been conducted and its methodology may be questioned.

A number of behavioural and cognitive features of OCD, including endophenotype markers that appear to characterise the disorder have been determined. These include a shift in cognitive control from a goal-directed strategy to a habitual (stimulus-response, S-R) strategy, cognitive rigidity in terms of both reversal learning and attentional set-shifting, impaired response inhibition and planning, and a tendency to over-respond to spurious negative feedback in a probabilistic learning paradigm. Neural substrates of these deficits are being investigated using brain imaging methodologies based on magnetic resonance and preliminary evidence suggests an over-active medial prefrontal cortex-caudate nucleus circuits and underactive lateral prefrontal cortex-putamen circuits. However, little evidence exists that relates to the hypothesis of an over-active habit system in this disorder or to the role of serotonin in all these cognitive and behavioural deficits observed in OCD and compulsivity in general.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals with high scores on obsessive-compulsive traits (with or without a diagnosis of OCD established by a psychiatrist) and healthy volunteers (male or female) between 18 and 70 years. Compulsive individuals without an OCD diagnosis are individuals without a history of psychiatric or other major medical conditions but scoring abnormally high on the Obsessive-Compulsive Inventory (OCI) questionnaire.

排除标准

  • Current or previous neurological disease, severe somatic disease, or consumption of medical drugs likely to influence the test results
  • Non- fluent in Danish or pronounced visual or auditory impairments
  • Current or past learning disability.
  • Pregnancy
  • Lactation
  • Participation in experiments with radioactivity (> 10 mSv) within the last year or significant occupational exposure to radioactivity.
  • Contraindications for MRI (pacemaker, metal implants, etc.).
  • Allergy to the ingredients in the administered drug.
  • Abnormal ECG (e.g. prolonged QT syndrome).
  • Dizzy when changing from supine to upright position (e.g. postural orthostatic tachycardia syndrome).
  • Mild hypotension (blood pressure below 100/70 mmHg) or hypertension (blood pressure above 140/90 mmHg).
  • Head injury or concussion resulting in loss of consciousness for more than 2 min.
  • Alcohol or drug abuse
  • Drug use other than tobacco and alcohol within the last 30 days.
  • Hash > 50 x lifetime.
  • Drugs > 10 x lifetime (for each substance).
  • Current medication with serotonergic acting compounds. Use of other psychoactive substances must be stable at least one month prior to inclusion and maintained throughout the study.
  • Severe physical impairments affecting eyesight or motor performance.
  • For the OCD group: other Axis I mental disorder as primary diagnosis according to ICD-10 criteria.
  • For healthy volunteers: any current or former primary psychiatric disorder (Axis I WHO ICD-10 diagnostic classification).

研究组 & 干预措施

Healthy Control Group

Placebo Comparator

The healthy placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

干预措施: Placebo oral tablet (Drug)

Obsessive-Compulsive Disorder / High Compulsivity Control Group

Placebo Comparator

The OCD/high compulsivity placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

干预措施: Placebo oral tablet (Drug)

Healthy Intervention Group

Experimental

The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

干预措施: Escitalopram (Drug)

Obsessive-Compulsive Disorder / High Compulsivity Intervention Group

Experimental

The OCD/high compulsivity intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

干预措施: Escitalopram (Drug)

结局指标

主要结局

Habit formation outcome 1: response times for each day of training

时间窗: 3 Years

Daily app training paradigm

Learning Primary Outcome 2 measured with Probability Reversal Learning test: Mean errors Stage 2 (Reversal)

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Habit formation outcome 3: confidence and enjoyable rates.

时间窗: 3 Years

Daily app training paradigm

Learning Primary Outcome 1 measured with Probability Reversal Learning test: Mean errors Stage 1 (Learning)

时间窗: 3 years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Inhibition Primary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Stop Signal Reaction Time

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains.

Flexibility Primary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Extra Dimensional Set Errors

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains.

Flexibility Primary Outcome 2 measured with Sequential model-based model-free test: Model-based Model-free Weight

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains.

Emotion Recognition Primary Outcome 1 measures with EMOTICOM Intensity Morphing: Affective bias in decreasing condition

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Emotion Recognition Primary Outcome 3 measured with EMOTICOM Intensity Morphing task: Detection threshold decreasing

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Learning Primary Outcome 3 measured with Deterministic Reversal Learning test: Percent correct per stage

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Emotion Recognition Primary Outcome 2 measured with EMOTICOM Emotion Recognition Task: Affective bias for D'

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Positron emission tomography (PET) Imaging: Cerebral [11C]SB207145 PET binding.

时间窗: 3 Years

Collected before and after participant's intervention.

Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Cohabit

时间窗: 3 Years

Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12Co-habit fMRI paradigm Imaging outcomes will be FWE corrected using Random Field Theory as implemented in SPM12.

Social Cognition Primary Outcome 1 measured with EMOTICOM Moral Emotions Task: Agent Guilt Score

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Social Cognition Primary Outcome 2 measured with EMOTICOM Moral Emotions Task: Agent Shame Score

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. The false discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Emotion Recognition Primary Outcome 4 measured with EMOTICOM Emotion Recognition task: D'Prime for emotion recognition

时间窗: 3 Years

Emotion Recognition Task. Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Memory Primary Outcome 1 measured with CANTAB Paired Associates Learning: Total Errors Adj

时间窗: 3 Years

Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.

Biofluids

时间窗: 3 Years

Serum Escitalopram levels

Diffusion Tensor Imaging MRI

时间窗: 3 Years

Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Slip of Actions

时间窗: 3 Years

Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

Habit formation outcome 2: mean errors per sequence and moves

时间窗: 3 Years

Daily app training paradigm

Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Faces

时间窗: 3 Years

Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

Resting State fMRI

时间窗: 3 Years

Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

Structural Voxel-based morphometry (VBM) MRI

时间窗: 3 Years

Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.

次要结局

  • Learning Secondary Outcome 2 measured with Probability Reversal Learning test: Stage 1 Reward/Punishment learning(3 Years)
  • Learning Secondary Outcome 4 measured with Probability Reversal Learning test: Stage 2 Reward-Stay/ Lose-Shift behaviour(3 Years)
  • Learning Secondary Outcome 5 measured with Probability Reversal Learning test: Stage 2 Reward/Punishment learning(3 Years)
  • Learning Secondary Outcome 7 measured with Deterministic Reversal Learning test: Reward-Stay/ Lose-Shift behaviour(3 Years)
  • Behavioural outcomes with Faces and geometric figure discrimination Outcome 2 measured with fMRI faces paradigm: Response Speed(3 Years)
  • Learning Secondary Outcome 6 measured with Probability Reversal Learning test: Stage 2. Stimulus Stickiness(3 Years)
  • Learning Secondary Outcome 1 measured with Probability Reversal Learning test: Stage 1 Reward-Stay/Lose-Shift behaviour(3 Years)
  • Learning Secondary Outcome 3 measured with Probability Reversal Learning test: Stage 1. Stimulus Stickiness(3 Years)
  • Inhibition Secondary Outcome 2 measured with Interleaved Stop Signal Task/Go-NoGo: Go omission error rate(3 Years)
  • Emotion Recognition Secondary Outcome 3 measured with EMOTICOM Emotion Recognition Task: Affective bias for Hit Rate(3 Years)
  • Flexibility Secondary Outcome 2 measured with Sequential Model-Based/Model-Free test: Exploration(3 Years)
  • Flexibility Secondary Outcome 3 measured with Sequential Model-Based/Model-Free test: Stimulus Stickiness(3 Years)
  • Flexibility Secondary Outcome 5 measured with 3Dimensional Intra/Extra Dimensional Shift test: Pre Extra Dimension Set Errors(3 Years)
  • Flexibility Secondary Outcome 6 measured with 3Dimensional Intra/Extra Dimensional Shift test: Latency(3 Years)
  • Inhibition Secondary Outcome 4 measured with Interleaved Stop Signal Task/Go-NoGo: No-Go error rate(3 Years)
  • Emotion Recognition Secondary Outcome 4 measured with EMOTICOM Emotion Recognition Task.: Hit Rate for Emotion Recognition(3 Years)
  • Behavioural outcomes with fMRI paradigm Co-habit: accuracy and latency.(3 Years)
  • Executive Function Secondary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Total Errors Adjusted(3 Years)
  • Memory Outcome 2 measured with Letter-number sequencing test: Total score(3 Years)
  • Risky Decision Making Outcome 3 measured with EMOTICOM Cambridge Gamble Task: Overall Proportion Bet(3 Years)
  • Risky Decision Making Outcome 4 measured with EMOTICOM Cambridge Gamble Task: Deliberation Time(3 Years)
  • Interpersonal Reactivity Index (IRI) Score(3 Years)
  • State and Trait Aggression Questionnaire Score(3 Years)
  • Visual Analogue Scale Score(3 Years)
  • Flexibility Secondary Outcome 1 measured with Sequential Model-Based/Model-Free test: Proportion of Stays(3 Years)
  • Inhibition Secondary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Go reaction time(3 Years)
  • Inhibition Secondary Outcome 3 measured with Interleaved Stop Signal Task/Go-NoGo: Go commission error rate(3 Years)
  • Emotion Recognition Secondary Outcome 1 measured with EMOTICOM Intensity Morphing Task: Detection threshold increasing(3 Years)
  • Emotion Recognition Secondary Outcome 2 measured with EMOTICOM Intensity Morphing Task: Affective bias in increasing condition(3 Years)
  • Memory Primary outcome 3 measured with Verbal Affective Memory Test-26: Latent variable model of the association between positive, negative and neutral word recall and 5-HT4R binding(3 Years)
  • Flexibility Secondary Outcome 4 measured with Sequential Model-Based/Model-Free test: Learning rate(3 Years)
  • Faces and geometric figure discrimination Outcome 1 measured with fMRI faces paradigm: Accuracy(3 Years)
  • Behavioural outcomes with fMRI paradigm slip of Actions : accuracy and latency(3 Years)
  • Psychomotor Speed Outcome 1 measured with CANTAB Reaction Time Task: Simple reaction time(3 Years)
  • Obsessive- Compulsive Inventory (OCI)- state Score(3 Years)
  • Risky Decision Making Outcome Outcome 1 measured with EMOTICOM Cambridge Gamble Task: Quality of Decision Making(3 Years)
  • Risky Decision Making Outcome 2 measured with EMOTICOM Cambridge Gamble Task: Risk Adjustment(3 Years)
  • Barratt Impulsiveness Scale-State Score(3 Years)
  • Memory Outcome 1 measured with CANTAB Paired Associates Learning test: First Trial Memory Score(3 Years)
  • Obsessive- Compulsive Inventory- trait Score(3 Years)
  • State-Trait Anxiety Inventory Scale Score(3 Years)
  • Intelligence Quotient (IQ) outcome 1 measured with Reynolds Intellectual assessment Scales subtest "guess what" and "what does not fit": Total age adjusted score(3 Years)
  • Brief Symptom Inventory (BSI) Score(3 Years)
  • Pittsburgh Sleep Quality Index Score(3 Years)
  • Profile of Mood State Score(3 Years)
  • Beck Depression Inventory-II Score(3 Years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gitte Moos Knudsen

Professor, MD, DMSc

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验

The Role of Serotonin in Compulsive Behavior in... | 临床试验